<DOC>
	<DOCNO>NCT01856699</DOCNO>
	<brief_summary>Aim SuSPect-CAA study prospectively evaluate prognostic significance cortical superficial siderosis patient suspect cerebral amyloid angiopathy primary focus future stroke mortality .</brief_summary>
	<brief_title>Superficial Siderosis Patients With Suspected Cerebral Amyloid Angiopathy</brief_title>
	<detailed_description>Non-traumatic cortical superficial siderosis ( cSS ) common find patient cerebral amyloid angiopathy ( CAA ) sole image sign . The clinical feature course well prognostic significance cSS CAA patient remain unclear . In retrospective study previously show cSS might important predictor warn sign future intracranial hemorrhage . However , prospective data miss . The Superficial Siderosis Patients suspect Cerebral Amyloid Angiopathy ( SuSPect-CAA ) study design prospective observational multi-centre cohort study . Primary objective study evaluate cSS predictor future stroke mortality ( primary endpoint : combine rate stroke death 36 month ) . Secondary objective study include 1 ) evaluate cSS represent marker future intracranial haemorrhage , especially site initial siderosis , 2 ) describe clinical presentation course cSS , 3 ) ass associate imaging finding , 4 ) determine differential diagnosis cSS . All subject present respective neurological center ( out- inpatient treatment neuroimaging ) screen . The study population consist two patient group : 1 ) Patients meet modify Boston criterion probable possible CAA , i. e. patient SS +/- lobar intracerebral hemorrhage microbleeds cortico-subcortical localization absence cause hemorrhage CAA assign study group . 2 ) Patients meet classic Boston criterion possible probable CAA without SS assign control group . A total 100 patient per group enrol . Baseline follow-up assessment 6 , 12 , 24 , 36 month perform visit respective neurological outpatient clinic include structure interview neurological exam , neuropsychological test , EEG MRI .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Amyloidosis</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<mesh_term>Cerebral Amyloid Angiopathy</mesh_term>
	<mesh_term>Cerebral Amyloid Angiopathy , Familial</mesh_term>
	<mesh_term>Siderosis</mesh_term>
	<criteria>Inclusion Criteria ( study group ) : Fulfillment modify Boston criterion CAArelated hemorrhage evidence supratentorial superficial siderosis MRI MR/CT/digital subtraction ( DS ) angiography without evidence cerebral aneurysm , arteriovenous malformation ( AVM ) , AVfistula pathology relevance ( e.g . tumor , hemorrhagic infarction ) A maximum two lobar cerebellar intracranial hemorrhage ( ICH ) ( old acute ) Written informed consent patient guardian prior study participation Willingness participate followup Inclusion Criteria ( control group ) : Fulfillment classic Boston criterion CAArelated hemorrhage Absence superficial siderosis MRI A maximum two lobar cerebellar ICHs ( old acute ) MR/CT/DS angiography without evidence cerebral aneurysm , AVM , AVfistula pathology relevance ( e.g . tumor , hemorrhagic infarction ) Written informed consent patient guardian prior study participation Willingness participate followup Exclusion Criteria ( group ) : Severe medical condition expect life expectancy &lt; 3 year More two lobar cerebellar ICH ( old acute ) intracerebral hemorrhage deep grey matter ( basal ganglion thalamus ) brain stem History head trauma result loss consciousness radiologically visible traumatic brain injury ( contusion , diffuse axonal damage ) last 5 year prior inclusion Cerebral aneurysm history aneurysmal subarachnoid hemorrhage Infratentorial siderosis Infratentorial subarachnoid hemorrhage</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>supratentorial superficial siderosis</keyword>
	<keyword>intracerebral hemorrhage</keyword>
	<keyword>cerebral amyloid angiopathy</keyword>
</DOC>